Brainstorm Cell Therapeutics Inc banner

Brainstorm Cell Therapeutics Inc
XBER:GHDN

Watchlist Manager
Brainstorm Cell Therapeutics Inc Logo
Brainstorm Cell Therapeutics Inc
XBER:GHDN
Watchlist
Price: 3.255 EUR
Market Cap: €1.2B

Profitability Summary

Brainstorm Cell Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Brainstorm Cell Therapeutics Inc

Margins Comparison
Brainstorm Cell Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
9.3m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
375.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
194.6B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
176B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.8B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.6B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.1B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
36.7B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Brainstorm Cell Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
9.3m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
375.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
194.6B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
176B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.8B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.6B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.1B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
36.7B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Brainstorm Cell Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett